Does Ejaculating Once a Week Help Prevent Prostate Cancer?

Ejaculating at least once a week seems to offer some protection against prostate cancer. But the strongest evidence points to higher frequencies, around 21 or more times per month, as the sweet spot where risk reduction really kicks in.

A large prospective study following nearly 32,000 men over 18 years found that men who ejaculated 21 or more times monthly had significantly lower prostate cancer risk compared to men who ejaculated four to seven times per month. Once a week puts you in a modest frequency range that's likely better than infrequent ejaculation, but the data suggest more frequent ejaculation may carry extra benefit.

This doesn't mean ejaculation is a prostate cancer cure or a standalone prevention strategy. It's one modifiable factor among several, and the evidence, while consistent, is observational in nature. What it does mean is that regular sexual activity isn't something men need to feel conflicted about from a health standpoint. For many men, it may be worth prioritising.

What the Research Actually Shows

The question has been studied seriously. The Health Professionals Follow-Up Study, which tracked men over decades, found a meaningful link between ejaculation frequency and prostate cancer risk. The 2016 updated analysis by Rider and colleagues remains one of the most cited pieces of evidence, showing that risk reduction was particularly notable for high-frequency ejaculation across a man's lifetime, including during his 20s and 40s.

A separate Australian cohort study found broadly consistent results. Men in the highest ejaculation frequency group had lower prostate cancer risk compared to men who ejaculated less often.

A 2018 meta-analysis examining sexual activity and prostate cancer risk found a dose-response relationship, higher frequency was associated with progressively lower risk. A 2024 narrative review consolidating the available evidence concluded that ejaculation frequency acts as a modifiable factor in prostate cancer risk, though the authors noted the need for further mechanistic research.

A case-control study published in 2017 found that higher ejaculatory frequency was associated with reduced odds of aggressive prostate cancer specifically. This matters clinically because aggressive disease is where mortality risk concentrates.

More recently, a 2025 paper explored the biological mechanisms that might explain these findings, pointing to prostatic fluid clearance, reduction of carcinogenic secretions, and hormonal regulation as plausible pathways.

Why Ejaculation Frequency Might Matter Biologically

The prostate gland produces fluid that contributes to semen. One leading hypothesis is that regular ejaculation flushes out potentially carcinogenic substances that accumulate in prostatic ducts over time. Infrequent ejaculation may allow these secretions to stagnate, increasing cellular exposure to compounds that could promote malignant change.

Hormonal regulation is another plausible mechanism. Testosterone and other androgens drive prostate cell growth, and evidence suggests that ejaculation patterns may influence androgen cycling in ways that reduce cumulative hormonal stress on prostate tissue.

Psychological stress reduction associated with regular sexual activity may also play an indirect role. We know chronic stress, inflammation, and cancer risk are linked.

None of these mechanisms are definitively proven in humans at the level of randomised trial evidence. But the epidemiological consistency across multiple large cohort studies is difficult to dismiss as coincidence.

Why Is Prostate Cancer So Common?

Prostate cancer is the most commonly diagnosed cancer in Australian men. Understanding why requires looking at a mix of factors that are largely non-modifiable alongside others where lifestyle genuinely matters.

Age is the dominant driver. The prostate undergoes cellular changes over decades, and the cumulative probability of malignant transformation rises sharply after 50. Most prostate cancers are diagnosed in men over 65.

This is partly why prostate cancer appears so prevalent, men are living longer, and more cancers are being detected through PSA screening that would previously have gone undiagnosed during a man's natural lifespan.

Genetics plays a substantial role. Men with a first-degree relative diagnosed with prostate cancer carry roughly double the population risk. Specific gene variants, including BRCA2 mutations more commonly associated with breast cancer, also elevate prostate cancer risk meaningfully.

Ethnicity influences incidence rates in ways that aren't fully explained by access to healthcare or screening alone, suggesting underlying biological differences in susceptibility.

Beyond biology, the modern environment contributes. High-fat diets, sedentary behaviour, obesity, and chronic inflammation are all associated with elevated prostate cancer risk. Exposure to certain industrial chemicals has also been implicated in some studies, though the data here is less consistent than for metabolic risk factors.

What Are the Main Causes of Prostate Cancer?

No single cause explains prostate cancer. It develops through an accumulation of genetic and environmental insults over time. Age-related DNA damage that escapes normal repair mechanisms is the fundamental process underlying most cases.

Androgens, particularly testosterone and its more potent derivative dihydrotestosterone, fuel the growth of prostate cells. Prostate cancers that develop are almost always androgen-sensitive in their early stages, which is why androgen deprivation is a primary treatment strategy.

Obesity and the metabolic changes associated with it, including elevated insulin-like growth factor levels and chronic low-grade inflammation, create a cellular environment that favours tumour development. A diet consistently high in processed red meat and saturated fat has been associated with higher risk in multiple population studies, while diets rich in tomato-derived lycopene and cruciferous vegetables have been associated with lower risk, though dietary studies carry inherent limitations.

Smoking has a weaker but real association with more aggressive prostate cancer at diagnosis. Heavy alcohol consumption, while more clearly linked to other cancers, has been flagged in some analyses as a modest risk factor.

Sexually transmitted infections causing chronic prostate inflammation have been studied as potential contributors. Some evidence suggests that recurrent prostatitis may increase cellular stress in a way that elevates risk over time.

Infrequent ejaculation now joins this list as a potentially modifiable factor. Though it sits at the lower end of the risk magnitude compared to age, family history, and metabolic health.

How to Reduce the Risk of Prostate Cancer

The evidence base for prostate cancer prevention is less complete than for some other cancers. But several strategies have meaningful support.

Weight management is one of the most actionable. Obesity, particularly central adiposity, is associated with more aggressive prostate cancer and worse outcomes. Achieving and maintaining a healthy weight through diet and regular physical activity addresses this directly while also reducing risk for cardiovascular disease and other cancers simultaneously.

Diet quality matters. Patterns that emphasise vegetables, legumes, whole grains, and fish over processed meats and refined carbohydrates are associated with lower prostate cancer incidence in observational data. The Mediterranean dietary pattern in particular has a reasonable evidence base for cancer risk reduction broadly, with plausible benefit for prostate health specifically.

Regular aerobic exercise has anti-inflammatory effects and helps regulate the hormonal environment that prostate cancer depends on. Men who exercise consistently tend to have lower rates of aggressive prostate cancer even after controlling for other variables.

Ejaculation frequency, based on the available evidence, belongs on this list. Aiming for higher frequency, ideally well above once per week based on studies showing maximal benefit at around 21 times monthly, is a low-risk behaviour with plausible biological mechanisms and consistent epidemiological support.

For men with a strong family history or other elevated risk factors, discussing PSA screening with a GP starting from age 40 to 50 is appropriate. Early detection remains one of the most effective tools available because prostate cancer caught at a localised stage is highly treatable.

How Can a Man Keep His Prostate Healthy?

Prostate health in a broad sense, encompassing benign prostatic hyperplasia, prostatitis, and cancer risk, is influenced by many of the same lifestyle factors. Staying hydrated supports urinary health and helps the prostate function normally.

Limiting caffeine and alcohol, particularly in men who already have lower urinary tract symptoms, reduces irritation of the bladder and prostate.

Pelvic floor health is often overlooked. Regular activity that strengthens the pelvic musculature supports normal urinary and sexual function and may reduce the discomfort associated with prostatitis. Men who sit for extended periods occupationally may benefit from regular movement breaks, as prolonged sitting places pressure on the perineal area and has been associated in some studies with elevated prostatitis risk.

Regular sexual activity, with or without a partner, supports prostate health through the fluid clearance mechanisms described above. The evidence for this extends beyond cancer prevention to general prostate function. Regular ejaculation appears to reduce the likelihood of prostatic congestion, a condition associated with pelvic pain and discomfort in some men.

Avoiding unnecessary antibiotic use while treating confirmed infections promptly matters because chronic bacterial prostatitis, if undertreated, can cause sustained inflammation that stresses prostate tissue over time.

Any urinary symptoms, difficulty initiating urination, weak stream, increased frequency, or blood in urine or semen, warrant assessment by a GP or urologist rather than watchful waiting.

When to See a Specialist

Lifestyle modification and attention to ejaculation frequency are appropriate prevention-focused strategies for healthy men. They're not a substitute for clinical assessment when symptoms arise or when risk factors are significant.

Men with a family history of prostate or breast cancer, particularly those with known BRCA mutations in the family, should discuss prostate surveillance proactively with their doctor rather than waiting for symptoms to develop.

PSA testing remains a useful but imperfect screening tool. It requires interpretation in clinical context rather than in isolation, and decisions about whether to investigate an elevated PSA with biopsy involve weighing the harms of overdiagnosis against the benefit of early detection. A urologist with experience in prostate cancer can guide these decisions in a way that is individualised rather than algorithmic.

For men concerned about their prostate health in Australia, physiotherapy services specialising in pelvic health can also form part of a broader management plan, particularly for men dealing with prostatitis or post-treatment recovery from prostate cancer. A multidisciplinary approach tends to produce better functional outcomes than any single intervention in isolation.